Abstract
203 BL-8040, a CXCR4 antagonist, synergizes with the FLT3 inhibitor AC220 inducing apoptosis and reducing minimal residual disease to prolong survival of AML diseased mice Yaron Pereg, Hanna Wald, Orly Eizenberg, Baruch Bulvik, Sigal Tavor, Katia Beider, Arnon Nagler, Leah Klapper, Amnon Peled, Michal Abraham BioLineRx LTD, Jerusalem, Israel; Biokine Therapeutics Ltd, Ness Ziona, Israel; Goldyne Savad Institute of Gene Therapy, Hebrew University Hospital, Jerusalem, Israel; Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Israel
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
